Targeted Clincial Trials to Reduce the Risk of Antimocribal Resistance
$2,842,831N01FY2010AINIH
Wayne State University, Detroit MI
Investigators
Abstract
To evaluate strategies that test the safety and effectiveness of therapeutic approaches/regimens to reduce the probability of the emergence of antibiotic drug resistance by minimizing unnecessary drug exposure.
View original record on NIH RePORTER →